Journal of the American Veterinary Medical Association · 1988 · 31 citations · 0 references
MedicinePharmacologyVeterinary PharmacologyBehavioral PharmacologyPharmacodynamicsPsychopharmacologyOpioid AnalgesicsOpioid ManagementOpioid PharmacologyOpioid TherapyPsychostimulant PharmacologyVeterinary NeuropharmacologyOpioid Antagonist TherapyOpioid Receptor Agonists
Nalmefene, an opioid antagonist, caused a decrease in self-mutilative behavior in a 500-kg stallion. Self-mutilative attempts were counted during a control period and on 4 subsequent occasions after the IM administration of 100 mg, 200 mg, 400 mg, or 800 mg of nalmefene. The frequency of self-mutilation decreased with increasing doses of nalmefene and was virtually abolished with the 800-mg dose.